In lung cancer-initiating cells, miR-145 downregulates stem-like properties and EMT via blocking Oct4 [170]; alternatively, in NSCLC, miR-145 and -203 are involved in TGF-β-related EMT inhibition through targeting SMAD3 [171]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.